Eli Lilly And Co LLY is one of several companies benefitting from demand for weight loss drugs. The company is also seeing competition in the market including knockoff drugs that it said could be unsafe . What Happened: A recent report says Eli Lilly is seeking medical records of people who took knockoff weight loss drugs.
The request, reported by Bloomberg , is being done for safety reasons according to the pharmaceutical company. Eli Lilly is building a case against businesses that are selling knockoffs of the company's Zepbound and Monjaro. Compounding pharmacies have been capitalizing on Lilly seeing supply constraints and shortages while demand remains high.
Lilly has said that the quality of the compounding pharmacies products are inferior and questions the safety profile of the treatment. A letter viewed by Bloomberg requested information from a patient who took a Lilly product from a compounded pharmacy. "We would appreciate if you could complete the enclosed form and sign the Authorization for Release of Medical Information so that we can obtain more details from the treating physician around your experience," the letter says.
Along with items like the letter, Eli Lilly also took out an advertisement in national publications encouraging patients to make sure they are taking the "real product." Read Also: Can Novo Nordisk’s Weight Loss Drug Ozempic Help Stem The Devastating Addiction Crisis? New Research Says Yes Why It's Important : Obtaining medical records could .
